Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies. J of Skin 2020, 4 (5), s46. https://doi.org/10.25251/skin.4.supp.46.